Pharma Journalist -

Merck, known as MSD outside the United States and Canada, and Hanmi Pharmaceutical announced that the companies have entered into an exclusive licensing agreement for the development,…
Read More...

GS CORPORATION Japan's leading pharma wholesaler and distributor announced a multi-year strategic business alliance agreement to create an integrated regenerative medicine supply chain…
Read More...

MYR Pharmaceuticals, a German biotechnology company focused on the development and commercialization of therapeutics for the treatment of chronic hepatitis B and D, is pleased to…
Read More...

Catalent announced that it will expand its Argentinian site in Loma Hermosa, Buenos Aires. The expansion, which will add over 11,000 square feet of production space at the facility,…
Read More...

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Seismic Bio, Inc., an…
Read More...

ReViral Ltd., a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics that target respiratory syncytial virus (RSV),…
Read More...

Cellix Bio Pharma completes the acquisition of Avaca Pharma, a formulation development company. Avaca Pharma services include discovery, formulation development, regulatory support, and…
Read More...

SMi reports: Brian Levy, CEO, Ocunexus Therapeutics will lead the post conference workshop on Wednesday 25th November 2020. SMi presents the 4th Annual Ophthalmic Drugs Conference…
Read More...

SMi Reports: Due to the ongoing challenges surrounding COVID-19 and large public gatherings, September’s Pre-filled Syringes San Francisco conference will now run as a virtual event.…
Read More...

G1 Therapeutics, Inc. and Simcere Pharmaceutical Group announced an exclusive license agreement for the development and commercialization of trilaciclib across all indications in…
Read More...